Udo Bavendiek

4.1k total citations
76 papers, 2.9k citations indexed

About

Udo Bavendiek is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Immunology. According to data from OpenAlex, Udo Bavendiek has authored 76 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Cardiology and Cardiovascular Medicine, 20 papers in Molecular Biology and 12 papers in Immunology. Recurrent topics in Udo Bavendiek's work include Cardiovascular Function and Risk Factors (10 papers), Cardiomyopathy and Myosin Studies (10 papers) and Cardiac electrophysiology and arrhythmias (9 papers). Udo Bavendiek is often cited by papers focused on Cardiovascular Function and Risk Factors (10 papers), Cardiomyopathy and Myosin Studies (10 papers) and Cardiac electrophysiology and arrhythmias (9 papers). Udo Bavendiek collaborates with scholars based in Germany, United States and Spain. Udo Bavendiek's co-authors include Johann Bauersachs, Robert H. G. Schwinger, Peter Libby, Uwe Schönbeck, Michael Böhm, Markus Flesch, Erland Erdmann, Bernhard Schieffer, Ulrich Schmidt and Peter Karczewski and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Nature Medicine.

In The Last Decade

Udo Bavendiek

70 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Udo Bavendiek Germany 26 1.2k 1.1k 755 443 308 76 2.9k
Florian Blaschke Germany 31 1.0k 0.9× 1.4k 1.3× 342 0.5× 245 0.6× 281 0.9× 108 3.4k
Isabel Gonçalves Sweden 34 1.2k 1.0× 852 0.8× 1.2k 1.6× 271 0.6× 235 0.8× 170 3.7k
Philipp J. Hohensinner Austria 30 1.4k 1.1× 444 0.4× 925 1.2× 354 0.8× 135 0.4× 76 3.1k
Gabrielle Paulsson‐Berne Sweden 32 1.2k 1.0× 477 0.4× 1.2k 1.6× 225 0.5× 156 0.5× 57 3.0k
Peter Kanellakis Australia 35 972 0.8× 582 0.5× 1.7k 2.3× 231 0.5× 232 0.8× 58 3.3k
Maren Luchtefeld Germany 20 652 0.5× 592 0.5× 822 1.1× 400 0.9× 96 0.3× 33 2.4k
Bruce A. Hug United States 23 1.6k 1.3× 502 0.5× 590 0.8× 316 0.7× 84 0.3× 47 3.6k
Shiro Kitamoto Japan 31 1.3k 1.1× 713 0.7× 1.2k 1.6× 507 1.1× 182 0.6× 52 3.8k
Bahjat Al‐Ani Saudi Arabia 30 816 0.7× 321 0.3× 646 0.9× 267 0.6× 159 0.5× 94 3.4k
Mona Skjelland Norway 29 804 0.7× 487 0.4× 695 0.9× 270 0.6× 114 0.4× 67 2.4k

Countries citing papers authored by Udo Bavendiek

Since Specialization
Citations

This map shows the geographic impact of Udo Bavendiek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Udo Bavendiek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Udo Bavendiek more than expected).

Fields of papers citing papers by Udo Bavendiek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Udo Bavendiek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Udo Bavendiek. The network helps show where Udo Bavendiek may publish in the future.

Co-authorship network of co-authors of Udo Bavendiek

This figure shows the co-authorship network connecting the top 25 collaborators of Udo Bavendiek. A scholar is included among the top collaborators of Udo Bavendiek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Udo Bavendiek. Udo Bavendiek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bauersachs, Johann, et al.. (2026). Digitalis – back on centre stage for HFrEF. European Journal of Heart Failure.
2.
Hohmann, Stephan, Udo Bavendiek, Tibor Kempf, et al.. (2025). Right Ventricular Dysfunction for Prediction of Long-Term Recovery in de novo HFrEF : A PROLONG-II Substudy. ESC Heart Failure. 12(3). 2166–2176. 3 indexed citations
3.
Kempf, Tibor, Jan Fuge, Marius M. Hoeper, et al.. (2025). Oral Ferric Maltol Improves Iron Deficiency Anaemia in Patients with Chronic Heart Failure. European Journal of Heart Failure. 27(11). 2325–2327. 1 indexed citations
4.
Grote‐Levi, Lea, Anja Hänselmann, Sandra Nay, et al.. (2025). Polyneuropathy in hereditary and wildtype transthyretin amyloidosis, comparison of key clinical features and red flags. Scientific Reports. 15(1). 35028–35028.
5.
Berliner, Dominik, Timo Buhl, Johann Bauersachs, et al.. (2024). Symptom severity reflected by NYHA grade is independently associated with pruritus in chronic heart failure patients. Journal of the European Academy of Dermatology and Venereology. 38(7). 1410–1418.
6.
Krefting, Dagmar, Udo Bavendiek, Joachim E. Fischer, et al.. (2024). Die digitalen Fortschrittshubs Gesundheit – Gemeinsame Datennutzung über die Universitätsmedizin hinaus. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 67(6). 701–709. 3 indexed citations
7.
Sieweke, Jan‐Thorben, Dominik Berliner, Stephan Hohmann, et al.. (2023). Echocardiographic parameters indicating left atrial reverse remodeling after catheter ablation for atrial fibrillation. Frontiers in Cardiovascular Medicine. 10. 1270422–1270422. 2 indexed citations
8.
Sonnenschein, Kristina, Jan Fiedler, David de Gonzalo‐Calvo, et al.. (2021). Blood-based protein profiling identifies serum protein c-KIT as a novel biomarker for hypertrophic cardiomyopathy. Scientific Reports. 11(1). 1755–1755. 9 indexed citations
9.
Sieweke, Jan‐Thorben, Tobias J. Pfeffer, Shambhabi Chatterjee, et al.. (2020). miR−21 and NT-proBNP Correlate with Echocardiographic Parameters of Atrial Dysfunction and Predict Atrial Fibrillation. Journal of Clinical Medicine. 9(4). 1118–1118. 25 indexed citations
10.
Kattih, Badder, Piroska Klement, Abel Martin Garrido, et al.. (2020). IDH1/2 mutations in acute myeloid leukemia patients and risk of coronary artery disease and cardiac dysfunction—a retrospective propensity score analysis. Leukemia. 35(5). 1301–1316. 37 indexed citations
11.
Bavendiek, Udo, et al.. (2020). A Structured Measurement of Highly Synchronous Real-Time Ballistocardiography Signal Data of Heart Failure Patients. Studies in health technology and informatics. 270. 808–812. 1 indexed citations
12.
Bavendiek, Udo, Dominik Berliner, Lukas Aguirre Dávila, et al.. (2019). Rationale and Design of the DIGIT-HF Trial (DIGitoxin to Improve Outcomes in Patients with Advanced Chronic Heart Failure): A Randomized, Double-Blind, Placebo-Controlled Study. European Journal of Heart Failure. 21(5). 676–684. 45 indexed citations
13.
Sonnenschein, Kristina, David de Gonzalo‐Calvo, Angelika Pfanne, et al.. (2019). Serum circular RNAs act as blood-based biomarkers for hypertrophic obstructive cardiomyopathy. Scientific Reports. 9(1). 20350–20350. 57 indexed citations
14.
Haghikia, Arash, Arslan Arinc Kayacelebi, Erik Hanff, et al.. (2017). The role of l-arginine/l-homoarginine/nitric oxide pathway for aortic distensibility and intima-media thickness in stroke patients. Amino Acids. 49(6). 1111–1121. 31 indexed citations
15.
Caobelli, Federico, Tim Wollenweber, Udo Bavendiek, et al.. (2016). Simultaneous dual-isotope solid-state detector SPECT for improved tracking of white blood cells in suspected endocarditis. European Heart Journal. 38(6). ehw231–ehw231. 41 indexed citations
16.
Akin, Muharrem, et al.. (2016). Mid-term results of interventional closure of patent foramen ovale with the Occlutech Figulla® Flex II Occluder. BMC Cardiovascular Disorders. 16(1). 217–217. 7 indexed citations
17.
Derda, Anselm A., Sabrina Thum, Johan M. Lorenzen, et al.. (2015). Blood-based microRNA signatures differentiate various forms of cardiac hypertrophy. International Journal of Cardiology. 196. 115–122. 81 indexed citations
18.
Kempf, Tibor, Alexander Zarbock, Christian Widera, et al.. (2011). GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice. Nature Medicine. 17(5). 581–588. 397 indexed citations
19.
Luchtefeld, Maren, Karsten Grote, Christina Grothusen, et al.. (2005). Angiotensin II induces MMP-2 in a p47phox-dependent manner. Biochemical and Biophysical Research Communications. 328(1). 183–188. 105 indexed citations
20.
Schwinger, Robert H. G., Klara Brixius, Udo Bavendiek, et al.. (1997). Effect of Cyclopiazonic Acid on the Force-Frequency Relationship in Human Nonfailing  Myocardium. Journal of Pharmacology and Experimental Therapeutics. 283(1). 286–292. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Florian Blaschke Breakdown of academic impact, for papers by Isabel Gonçalves Breakdown of academic impact, for papers by Philipp J. Hohensinner Breakdown of academic impact, for papers by Gabrielle Paulsson‐Berne Breakdown of academic impact, for papers by Peter Kanellakis Breakdown of academic impact, for papers by Maren Luchtefeld Breakdown of academic impact, for papers by Bruce A. Hug Breakdown of academic impact, for papers by Shiro Kitamoto Breakdown of academic impact, for papers by Bahjat Al‐Ani Breakdown of academic impact, for papers by Mona Skjelland
Rankless by CCL
2026